Skip to main content

Unfortunately we don't fully support your browser. If you have the option to, please upgrade to a newer version or use Mozilla Firefox, Microsoft Edge, Google Chrome, or Safari 14 or newer. If you are unable to, and need support, please send us your feedback.

We'd appreciate your feedback.Tell us what you think!

Elsevier
Publish with us

Profile

Jin-Quan Yu

JY

Jin-Quan Yu

The Scripps Research Institute, USA

Rational-design and unexpected discovery of new reactions through C-H activation.

Our program centers around the discovery of catalytic carbon-carbon and carbon-heteroatom bond forming reactions based on C-H activation. Target transformations are selected to enable 1) the use of simple and abundant starting materials such as aliphatic acids, amines and alcohols, and 2) disconnections that drastically shorten the synthesis of drug molecules or a major class of biologically active compounds. Ultimately, we hope to develop catalytic reactions to parallel enzymatic transformations in terms of reactivity and selectivity. To achieve this goal, our research activities are directed towards the following main aspects: C-H activation, sustainable catalysis, asymmetric catalysis and synthetic applications.

Major components of training for students are organometallic chemistry, asymmetric catalysis (synthesis and characterization of organometallic complexes as catalysts or intermediates; ligand design for chiral control or acceleration) and organic synthesis (in the context of drug discovery and natural product synthesis). We collaborate extensively with computational groups via NSF center (Professor Jamal Musaev, Emory University, Professor Ken Houk, UCLA), as well as pharmaceutical and agrochemical industry (BMS and Syngenta) and Aldrich. We have research projects on the following topics: C-H activation (how to cleave C-H bonds without using forceful conditions?); Catalysis (how to close catalytic cycles under practical conditions?); and Synthetic applications (how to shorten synthetic routes for natural products and drug molecules?).